GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways

Jiang Pi(Macau University of Science and Technology), Zheng W. Chen(University of Illinois Chicago)
Drug Delivery
January 1, 2017
Cited by 99


Related Papers